February 28, 2026
MRK · NYQ · USD
vs. prev. close $119.3
Last updated Feb 27, 2026 21:02
Intraday Chart — 5-min intervals
Merck & Co., Inc. (MRK) is trading notably up, at $123.82 — up 3.79% from yesterday's close of $119.30. Recent news includes "Merck Reshapes Drug Business As Keytruda Era Nears Turning Point" and "These Stocks Lead Dow Jones In February. Hint: It's Not AI Companies.". The broader market is under pressure (S&P 500: -0.4%, Nasdaq: -0.9%, Dow Jones: -1.1%, Shanghai: +0.4%, Hang Seng: +0.9%, Nikkei 225: +0.2%, FTSE 100: +0.6%, Nifty 50: -1.2%, DAX: -0.0%, OMX Stockholm: +0.5%). Past performance does not guarantee future results.
Auto-generated · less than a minute ago
Merck Reshapes Drug Business As Keytruda Era Nears Turning Point
These Stocks Lead Dow Jones In February. Hint: It's Not AI Companies.
Merck Stock, Up 18% In 2026, Ticks Another Box. Is It Now A Buy?
Sector Update: Health Care Stocks Advance Late Afternoon
Sunrun stock nosedives on outlook, Merck job cuts, Jefferies sinks
Sector Update: Health Care Stocks Higher Friday Afternoon
Sector Update: Health Care
Merck Says Keytruda Plus Padcev Decreases Risk of Death in Bladder Cancer Trial
S&P 500
-0.43%
Nasdaq
-0.92%
Dow Jones
-1.05%
Shanghai
+0.39%
Hang Seng
+0.95%
Nikkei 225
+0.16%
FTSE 100
+0.59%
Nifty 50
-1.25%
DAX
-0.02%
OMX Stockholm
+0.55%
Search another stock